Medicenna Therapeutics Corp Stock Price on November 15, 2024
| MDNA Stock | CAD 1.72 0.06 3.37% |
Below is the normalized historical share price chart for Medicenna Therapeutics Corp extending back to July 14, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Medicenna Therapeutics stands at 1.72, as last reported on the 30th of November, with the highest price reaching 1.80 and the lowest price hitting 1.66 during the day.
If you're considering investing in Medicenna Stock, it is important to understand the factors that can impact its price. Medicenna Therapeutics has Sharpe Ratio of -0.0824, which conveys that the firm had a -0.0824% return per unit of risk over the last 3 months. Medicenna Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medicenna Therapeutics' Risk Adjusted Performance of (0.01), mean deviation of 3.97, and Standard Deviation of 5.3 to check out the risk estimate we provide.
At this time, Medicenna Therapeutics' Common Stock is very stable compared to the past year. As of the 30th of November 2024, Common Stock Total Equity is likely to grow to about 68.3 M, while Total Stockholder Equity is likely to drop about 4.9 M. . At this time, Medicenna Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 30th of November 2024, Price Earnings To Growth Ratio is likely to grow to 0, while Price Earnings Ratio is likely to drop (5.20). Medicenna Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 1.9835 | 50 Day MA 2.0438 | Beta 1.189 |
Medicenna |
Sharpe Ratio = -0.0824
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MDNA |
Estimated Market Risk
| 5.12 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.42 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Medicenna Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medicenna Therapeutics by adding Medicenna Therapeutics to a well-diversified portfolio.
Price Book 6.938 | Book Value 0.075 | Enterprise Value 108.9 M | Enterprise Value Ebitda (6.11) | Shares Float 49.8 M |
Medicenna Therapeutics Main Headline on 15th of November 2024
Medicennas MDNA11 Drug Shows 30 percent Response Rate, Stron... by news.google.com
Medicennas MDNA11 Drug Shows 30 percent Response Rate, Strong Results in Cancer Trial MDNAF Stock News StockTitan
Medicenna Therapeutics Valuation on November 15, 2024
It is possible to determine the worth of Medicenna Therapeutics on a given historical date. On November 15, 2024 Medicenna was worth 1.69 at the beginning of the trading date compared to the closed value of 1.45. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Medicenna Therapeutics stock. Still, in general, we apply an absolute valuation method to find Medicenna Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medicenna Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Medicenna Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.70 | 1.91 | 1.69 | 1.70 | 102,196 | |
11/15/2024 | 1.69 | 1.71 | 1.27 | 1.45 | 201,328 |
| 1.47 | 1.63 | 1.46 | 1.61 | 76,180 |
| Backtest Medicenna Therapeutics | | | Medicenna Therapeutics History | | | Medicenna Therapeutics Valuation | Previous | Next |
Medicenna Therapeutics Trading Date Momentum on November 15, 2024
| On November 18 2024 Medicenna Therapeutics Corp was traded for 1.61 at the closing time. The highest price during the trading period was 1.63 and the lowest recorded bid was listed for 1.46 . The volume for the day was 76.2 K. This history from November 18, 2024 contributed to the next trading day price boost. The trading delta at closing time to the next closing price was 11.03% . The trading delta at closing time to the current price is 10.34% . |
Medicenna Therapeutics Fundamentals Correlations and Trends
By evaluating Medicenna Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Medicenna Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Medicenna financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Medicenna Therapeutics Stock history
Medicenna Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Medicenna is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Medicenna Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Medicenna Therapeutics stock prices may prove useful in developing a viable investing in Medicenna Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 69.6 M | 38.4 M | |
| Net Loss | -9 M | -9.5 M |
Medicenna Therapeutics Quarterly Net Working Capital |
|
Medicenna Therapeutics Stock Technical Analysis
Medicenna Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Medicenna Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Medicenna Therapeutics Corp cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Medicenna Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Medicenna Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Medicenna Therapeutics shares will generate the highest return on investment. By undertsting and applying Medicenna Therapeutics stock market strength indicators, traders can identify Medicenna Therapeutics Corp entry and exit signals to maximize returns
Medicenna Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Medicenna Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Medicenna Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Medicenna to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (1.03) | |||
| Treynor Ratio | (0.15) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Medicenna Stock
Medicenna Therapeutics financial ratios help investors to determine whether Medicenna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicenna with respect to the benefits of owning Medicenna Therapeutics security.